Literature DB >> 27534681

Mortality reduction in adult community-acquired pneumonia in the UK (2009-2014): results from the British Thoracic Society audit programme.

Priya Daniel1, Mark Woodhead2, Sally Welham3, Tricia M Mckeever4, Wei Shen Lim1.   

Abstract

Community-acquired pneumonia (CAP) is a leading cause of death in the UK. In this analysis of 23 315 cases from the British Thoracic Society national CAP audit, an overall reduction in 30-day inpatient mortality over 6 years was observed-2014 compared with 2009 adjusted OR 0.86 (95% CI 0.68 to 1.08, p for trend 0.004). Significant increases in the proportions of patients who had (a) a chest X-ray and (b) the first antibiotic dose within 4 hours of admission were also observed (3.7% and 11.5% increases respectively). Further reductions in mortality may follow the 2016 National Institute for Health and Care Excellence Pneumonia Quality Standard. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Clinical Epidemiology; Pneumonia; Respiratory Infection

Mesh:

Substances:

Year:  2016        PMID: 27534681     DOI: 10.1136/thoraxjnl-2016-208937

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Corticosteroids for Community-Acquired Pneumonia: Overstated Benefits and Understated Risks.

Authors:  Grant Waterer; Mark L Metersky
Journal:  Chest       Date:  2019-07-06       Impact factor: 9.410

Review 2.  Burden of Community-Acquired Pneumonia and Unmet Clinical Needs.

Authors:  João Ferreira-Coimbra; Cristina Sarda; Jordi Rello
Journal:  Adv Ther       Date:  2020-02-18       Impact factor: 3.845

Review 3.  Variation in clinical outcomes and process of care measures in community acquired pneumonia: a systematic review.

Authors:  H Lawrence; W S Lim; T M McKeever
Journal:  Pneumonia (Nathan)       Date:  2020-09-25

4.  The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.

Authors:  Ruo-Xuan Dai; Qing-Hua Kong; Bei Mao; Wen Xu; Ru-Jia Tao; Xiao-Ru Wang; Qing-Yao Kong; Jin-Fu Xu
Journal:  BMC Pulm Med       Date:  2018-01-22       Impact factor: 3.317

5.  A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days.

Authors:  Daniel G Wootton; Laura Dickinson; Henry Pertinez; Joanne Court; Odiri Eneje; Lynne Keogan; Laura Macfarlane; Sarah Wilks; Jane Gallagher; Mark Woodhead; Stephen B Gordon; Peter J Diggle
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671

6.  Improved treatment of community-acquired pneumonia through tailored interventions: Results from a controlled, multicentre quality improvement project.

Authors:  Markus Fally; Christian von Plessen; Jacob Anhøj; Thomas Benfield; Britta Tarp; Lise Notander Clausen; Lilian Kolte; Emma Diernaes; Line Molzen; Regitze Seerup; Simone Israelsen; Anne-Marie Blok Hellesøe; Pernille Ravn
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

7.  Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia.

Authors:  Catia Cillóniz; Adamantia Liapikou; Ignacio Martin-Loeches; Carolina García-Vidal; Albert Gabarrús; Adrian Ceccato; Daniel Magdaleno; Josep Mensa; Francesc Marco; Antoni Torres
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

8.  Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review.

Authors:  Rodrigo B Serafim; Pedro Póvoa; Vicente Souza-Dantas; André C Kalil; Jorge I F Salluh
Journal:  Clin Microbiol Infect       Date:  2020-10-23       Impact factor: 8.067

9.  Fever, Tachypnea, and Monocyte Distribution Width Predicts Length of Stay for Patients with COVID-19: A Pioneer Study.

Authors:  Sheng-Feng Lin; Hui-An Lin; Han-Chuan Chuang; Hung-Wei Tsai; Ning Kuo; Shao-Chun Chen; Sen-Kuang Hou
Journal:  J Pers Med       Date:  2022-03-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.